Advertisement

Topics

Blood Test Detects Resistance to BRCA-Targeting Drugs

10:02 EST 14 Nov 2017 | Globetech

Resistance to platinum-based chemotherapy or PARP inhibition in germline BRCA1 or BRCA2 mutation carriers may occur through somatic reversion mutations...

Original Article: Blood Test Detects Resistance to BRCA-Targeting Drugs

NEXT ARTICLE

More From BioPortfolio on "Blood Test Detects Resistance to BRCA-Targeting Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...